Hantavirus hemorrhagic fever with renal syndrome

disease
On this page

Also known as hemorrhagic fever, Russianhemorrhagic nephrosonephritisHFRSPuumala virus nephropathy

Summary

Hantavirus hemorrhagic fever with renal syndrome (MONDO:0005784) is a disease and 3 clinical trials. A subtype of renal infectious disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namehantavirus hemorrhagic fever with renal syndrome
Mondo IDMONDO:0005784
DOIDDOID:11266
ICD-10-CMA98.5
NCITC84753
SNOMED CT102455002
GARD0027728
Anatomy (UBERON)UBERON:0002113
Is cancer (heuristic)no

Also known as: hemorrhagic fever, Russian · hemorrhagic nephrosonephritis · HFRS · Puumala virus nephropathy

Disease family

This is a subtype of renal infectious disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › urinary system disorderkidney disorderrenal infectious diseasehantavirus hemorrhagic fever with renal syndrome

Related subtypes (3): renal tuberculosis, pyelonephritis, adenovirus renal infection

Subtypes (4): Hantavirus hemorrhagic fever with renal syndrome, Seoul virus type, Hantavirus hemorrhagic fever with renal syndrome, Puumala virus type, Hantavirus hemorrhagic fever with renal syndrome, Dobrava-Belgrade virus type, BK-virus nephropathy

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

PhaseTrials
PHASE41
PHASE21
Not specified1

Top trials by phase / activity

NCTPhaseStatusTitle
NCT06009042PHASE4UNKNOWNEfficacy of Intravenous Immunoglobulin in Patients With Hemorrhagic Fever With Renal Syndrome: a Prospective Study
NCT04333459PHASE2COMPLETEDSafety/Immunogenicity Hantaan Virus DNA Vaccine and Puumala Virus DNA Vaccine, For Prevention of HFRS
NCT06020326Not specifiedUNKNOWNA Retrospective Cohort Study of HFRS

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.